Skip Navigation


Journal of Intellectual Property Law & Practice Advance Access originally published online on January 25, 2008
Journal of Intellectual Property Law & Practice 2008 3(2):140-141; doi:10.1093/jiplp/jpm249
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
3/2/140    most recent
jpm249v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Islam, Md. R.
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author (2008). Published by Oxford University Press. All rights reserved

IP in Review

Review of Protection of Regulatory Data under Article 39.3 of TRIPs: The Indian Context

Md. Rizwanul Islam *
Protection of Regulatory Data under Article 39.3 of TRIPs: The Indian Context
Shamnad Basheer
Intellectual Property Institute, 2006
ISBN: 1-874001-91-X, Soft cover, pp. 22
£20.00.

The first 10% of the full text of this article appears below.

The development of pharmaceutical materials from innovation to finally entering the marketplace is a tedious and expensive one. A vital step in this development is obtaining statutory authorization to offer the product to the public. This entails the creation of substantial amounts of regulatory data to show the safety and effectiveness of the pharmaceutical. There is no agreement among WTO members or the scholarly community as to the level of protection that Article . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?